0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antibody Conjugation Service Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-23Y16143
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antibody Conjugation Service Market Research Report 2024
BUY CHAPTERS

Global Antibody Conjugation Service Market Research Report 2025

Code: QYRE-Auto-23Y16143
Report
September 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antibody Conjugation Service Market

The global market for Antibody Conjugation Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Antibody conjugation service refers to a process in which antibodies are chemically modified by attaching various tags or ligands to their specific binding sites, enabling them to bind to various targets such as cells, proteins, or other molecules. This process is typically performed by specialized laboratories or service providers using various conjugation techniques such as click conjugation, biotin-avidin binding, etc. The goal of this service is to improve the specificity and affinity of antibodies for their targets, as well as to enhance their functional capabilities.
The industry trend for antibody conjugation service is towards increasing use in pharmaceutical and biotechnology research and development, as well as in clinical settings. With the growing demand for more advanced and specific antibody-based diagnostic and therapeutic tools, antibody conjugation services are becoming increasingly important. Additionally, the increasing use of antibody-based drugs in oncology and other diseases is driving the demand for such services, as they enable the development of more effective and targeted treatment strategies. Furthermore, the trend towards more sustainable and environmentally friendly research and production methods is also contributing to the growth of antibody conjugation services, as they reduce the use of toxic chemicals and minimize the environmental impact of antibody production.
This report aims to provide a comprehensive presentation of the global market for Antibody Conjugation Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Conjugation Service.
The Antibody Conjugation Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody Conjugation Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Conjugation Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antibody Conjugation Service Market Report

Report Metric Details
Report Name Antibody Conjugation Service Market
Segment by Type
  • Chemical Compound
  • Fluorescent Group
  • Isotope
  • Protein
Segment by Application
  • Biotechnology
  • Medical
  • University
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ProSci, Inc, Thermo Fisher Scientific, Abcam, Cell Signaling Technology, Bio X Cell, SouthernBiotech, Novus Biologicals, GenScript, Leinco Technologies, Standard BioTools, AlphaThera, Creative Biolabs, Antibodies, Boster Biological Technology, Cygnus Technologies, Cayman Chemical, GeneTex, ProteoGenix, Levena Biopharma, Merck, Lonza, Charles River
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antibody Conjugation Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antibody Conjugation Service Market report?

Ans: The main players in the Antibody Conjugation Service Market are ProSci, Inc, Thermo Fisher Scientific, Abcam, Cell Signaling Technology, Bio X Cell, SouthernBiotech, Novus Biologicals, GenScript, Leinco Technologies, Standard BioTools, AlphaThera, Creative Biolabs, Antibodies, Boster Biological Technology, Cygnus Technologies, Cayman Chemical, GeneTex, ProteoGenix, Levena Biopharma, Merck, Lonza, Charles River

What are the Application segmentation covered in the Antibody Conjugation Service Market report?

Ans: The Applications covered in the Antibody Conjugation Service Market report are Biotechnology, Medical, University, Others

What are the Type segmentation covered in the Antibody Conjugation Service Market report?

Ans: The Types covered in the Antibody Conjugation Service Market report are Chemical Compound, Fluorescent Group, Isotope, Protein

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Conjugation Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemical Compound
1.2.3 Fluorescent Group
1.2.4 Isotope
1.2.5 Protein
1.3 Market by Application
1.3.1 Global Antibody Conjugation Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Conjugation Service Market Perspective (2020-2031)
2.2 Global Antibody Conjugation Service Growth Trends by Region
2.2.1 Global Antibody Conjugation Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antibody Conjugation Service Historic Market Size by Region (2020-2025)
2.2.3 Antibody Conjugation Service Forecasted Market Size by Region (2026-2031)
2.3 Antibody Conjugation Service Market Dynamics
2.3.1 Antibody Conjugation Service Industry Trends
2.3.2 Antibody Conjugation Service Market Drivers
2.3.3 Antibody Conjugation Service Market Challenges
2.3.4 Antibody Conjugation Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Conjugation Service Players by Revenue
3.1.1 Global Top Antibody Conjugation Service Players by Revenue (2020-2025)
3.1.2 Global Antibody Conjugation Service Revenue Market Share by Players (2020-2025)
3.2 Global Antibody Conjugation Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antibody Conjugation Service Revenue
3.4 Global Antibody Conjugation Service Market Concentration Ratio
3.4.1 Global Antibody Conjugation Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Conjugation Service Revenue in 2024
3.5 Global Key Players of Antibody Conjugation Service Head office and Area Served
3.6 Global Key Players of Antibody Conjugation Service, Product and Application
3.7 Global Key Players of Antibody Conjugation Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Conjugation Service Breakdown Data by Type
4.1 Global Antibody Conjugation Service Historic Market Size by Type (2020-2025)
4.2 Global Antibody Conjugation Service Forecasted Market Size by Type (2026-2031)
5 Antibody Conjugation Service Breakdown Data by Application
5.1 Global Antibody Conjugation Service Historic Market Size by Application (2020-2025)
5.2 Global Antibody Conjugation Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antibody Conjugation Service Market Size (2020-2031)
6.2 North America Antibody Conjugation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antibody Conjugation Service Market Size by Country (2020-2025)
6.4 North America Antibody Conjugation Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Conjugation Service Market Size (2020-2031)
7.2 Europe Antibody Conjugation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antibody Conjugation Service Market Size by Country (2020-2025)
7.4 Europe Antibody Conjugation Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Conjugation Service Market Size (2020-2031)
8.2 Asia-Pacific Antibody Conjugation Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antibody Conjugation Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Antibody Conjugation Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Conjugation Service Market Size (2020-2031)
9.2 Latin America Antibody Conjugation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antibody Conjugation Service Market Size by Country (2020-2025)
9.4 Latin America Antibody Conjugation Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Conjugation Service Market Size (2020-2031)
10.2 Middle East & Africa Antibody Conjugation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antibody Conjugation Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Antibody Conjugation Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ProSci, Inc
11.1.1 ProSci, Inc Company Details
11.1.2 ProSci, Inc Business Overview
11.1.3 ProSci, Inc Antibody Conjugation Service Introduction
11.1.4 ProSci, Inc Revenue in Antibody Conjugation Service Business (2020-2025)
11.1.5 ProSci, Inc Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Antibody Conjugation Service Introduction
11.2.4 Thermo Fisher Scientific Revenue in Antibody Conjugation Service Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Abcam
11.3.1 Abcam Company Details
11.3.2 Abcam Business Overview
11.3.3 Abcam Antibody Conjugation Service Introduction
11.3.4 Abcam Revenue in Antibody Conjugation Service Business (2020-2025)
11.3.5 Abcam Recent Development
11.4 Cell Signaling Technology
11.4.1 Cell Signaling Technology Company Details
11.4.2 Cell Signaling Technology Business Overview
11.4.3 Cell Signaling Technology Antibody Conjugation Service Introduction
11.4.4 Cell Signaling Technology Revenue in Antibody Conjugation Service Business (2020-2025)
11.4.5 Cell Signaling Technology Recent Development
11.5 Bio X Cell
11.5.1 Bio X Cell Company Details
11.5.2 Bio X Cell Business Overview
11.5.3 Bio X Cell Antibody Conjugation Service Introduction
11.5.4 Bio X Cell Revenue in Antibody Conjugation Service Business (2020-2025)
11.5.5 Bio X Cell Recent Development
11.6 SouthernBiotech
11.6.1 SouthernBiotech Company Details
11.6.2 SouthernBiotech Business Overview
11.6.3 SouthernBiotech Antibody Conjugation Service Introduction
11.6.4 SouthernBiotech Revenue in Antibody Conjugation Service Business (2020-2025)
11.6.5 SouthernBiotech Recent Development
11.7 Novus Biologicals
11.7.1 Novus Biologicals Company Details
11.7.2 Novus Biologicals Business Overview
11.7.3 Novus Biologicals Antibody Conjugation Service Introduction
11.7.4 Novus Biologicals Revenue in Antibody Conjugation Service Business (2020-2025)
11.7.5 Novus Biologicals Recent Development
11.8 GenScript
11.8.1 GenScript Company Details
11.8.2 GenScript Business Overview
11.8.3 GenScript Antibody Conjugation Service Introduction
11.8.4 GenScript Revenue in Antibody Conjugation Service Business (2020-2025)
11.8.5 GenScript Recent Development
11.9 Leinco Technologies
11.9.1 Leinco Technologies Company Details
11.9.2 Leinco Technologies Business Overview
11.9.3 Leinco Technologies Antibody Conjugation Service Introduction
11.9.4 Leinco Technologies Revenue in Antibody Conjugation Service Business (2020-2025)
11.9.5 Leinco Technologies Recent Development
11.10 Standard BioTools
11.10.1 Standard BioTools Company Details
11.10.2 Standard BioTools Business Overview
11.10.3 Standard BioTools Antibody Conjugation Service Introduction
11.10.4 Standard BioTools Revenue in Antibody Conjugation Service Business (2020-2025)
11.10.5 Standard BioTools Recent Development
11.11 AlphaThera
11.11.1 AlphaThera Company Details
11.11.2 AlphaThera Business Overview
11.11.3 AlphaThera Antibody Conjugation Service Introduction
11.11.4 AlphaThera Revenue in Antibody Conjugation Service Business (2020-2025)
11.11.5 AlphaThera Recent Development
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Details
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Antibody Conjugation Service Introduction
11.12.4 Creative Biolabs Revenue in Antibody Conjugation Service Business (2020-2025)
11.12.5 Creative Biolabs Recent Development
11.13 Antibodies
11.13.1 Antibodies Company Details
11.13.2 Antibodies Business Overview
11.13.3 Antibodies Antibody Conjugation Service Introduction
11.13.4 Antibodies Revenue in Antibody Conjugation Service Business (2020-2025)
11.13.5 Antibodies Recent Development
11.14 Boster Biological Technology
11.14.1 Boster Biological Technology Company Details
11.14.2 Boster Biological Technology Business Overview
11.14.3 Boster Biological Technology Antibody Conjugation Service Introduction
11.14.4 Boster Biological Technology Revenue in Antibody Conjugation Service Business (2020-2025)
11.14.5 Boster Biological Technology Recent Development
11.15 Cygnus Technologies
11.15.1 Cygnus Technologies Company Details
11.15.2 Cygnus Technologies Business Overview
11.15.3 Cygnus Technologies Antibody Conjugation Service Introduction
11.15.4 Cygnus Technologies Revenue in Antibody Conjugation Service Business (2020-2025)
11.15.5 Cygnus Technologies Recent Development
11.16 Cayman Chemical
11.16.1 Cayman Chemical Company Details
11.16.2 Cayman Chemical Business Overview
11.16.3 Cayman Chemical Antibody Conjugation Service Introduction
11.16.4 Cayman Chemical Revenue in Antibody Conjugation Service Business (2020-2025)
11.16.5 Cayman Chemical Recent Development
11.17 GeneTex
11.17.1 GeneTex Company Details
11.17.2 GeneTex Business Overview
11.17.3 GeneTex Antibody Conjugation Service Introduction
11.17.4 GeneTex Revenue in Antibody Conjugation Service Business (2020-2025)
11.17.5 GeneTex Recent Development
11.18 ProteoGenix
11.18.1 ProteoGenix Company Details
11.18.2 ProteoGenix Business Overview
11.18.3 ProteoGenix Antibody Conjugation Service Introduction
11.18.4 ProteoGenix Revenue in Antibody Conjugation Service Business (2020-2025)
11.18.5 ProteoGenix Recent Development
11.19 Levena Biopharma
11.19.1 Levena Biopharma Company Details
11.19.2 Levena Biopharma Business Overview
11.19.3 Levena Biopharma Antibody Conjugation Service Introduction
11.19.4 Levena Biopharma Revenue in Antibody Conjugation Service Business (2020-2025)
11.19.5 Levena Biopharma Recent Development
11.20 Merck
11.20.1 Merck Company Details
11.20.2 Merck Business Overview
11.20.3 Merck Antibody Conjugation Service Introduction
11.20.4 Merck Revenue in Antibody Conjugation Service Business (2020-2025)
11.20.5 Merck Recent Development
11.21 Lonza
11.21.1 Lonza Company Details
11.21.2 Lonza Business Overview
11.21.3 Lonza Antibody Conjugation Service Introduction
11.21.4 Lonza Revenue in Antibody Conjugation Service Business (2020-2025)
11.21.5 Lonza Recent Development
11.22 Charles River
11.22.1 Charles River Company Details
11.22.2 Charles River Business Overview
11.22.3 Charles River Antibody Conjugation Service Introduction
11.22.4 Charles River Revenue in Antibody Conjugation Service Business (2020-2025)
11.22.5 Charles River Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Antibody Conjugation Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Chemical Compound
 Table 3. Key Players of Fluorescent Group
 Table 4. Key Players of Isotope
 Table 5. Key Players of Protein
 Table 6. Global Antibody Conjugation Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Antibody Conjugation Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Antibody Conjugation Service Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Antibody Conjugation Service Market Share by Region (2020-2025)
 Table 10. Global Antibody Conjugation Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Antibody Conjugation Service Market Share by Region (2026-2031)
 Table 12. Antibody Conjugation Service Market Trends
 Table 13. Antibody Conjugation Service Market Drivers
 Table 14. Antibody Conjugation Service Market Challenges
 Table 15. Antibody Conjugation Service Market Restraints
 Table 16. Global Antibody Conjugation Service Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Antibody Conjugation Service Market Share by Players (2020-2025)
 Table 18. Global Top Antibody Conjugation Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Conjugation Service as of 2024)
 Table 19. Ranking of Global Top Antibody Conjugation Service Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Antibody Conjugation Service Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Antibody Conjugation Service, Headquarters and Area Served
 Table 22. Global Key Players of Antibody Conjugation Service, Product and Application
 Table 23. Global Key Players of Antibody Conjugation Service, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Antibody Conjugation Service Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Antibody Conjugation Service Revenue Market Share by Type (2020-2025)
 Table 27. Global Antibody Conjugation Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Antibody Conjugation Service Revenue Market Share by Type (2026-2031)
 Table 29. Global Antibody Conjugation Service Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Antibody Conjugation Service Revenue Market Share by Application (2020-2025)
 Table 31. Global Antibody Conjugation Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Antibody Conjugation Service Revenue Market Share by Application (2026-2031)
 Table 33. North America Antibody Conjugation Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Antibody Conjugation Service Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Antibody Conjugation Service Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Antibody Conjugation Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Antibody Conjugation Service Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Antibody Conjugation Service Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Antibody Conjugation Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Antibody Conjugation Service Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Antibody Conjugation Service Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Antibody Conjugation Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Antibody Conjugation Service Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antibody Conjugation Service Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Antibody Conjugation Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Antibody Conjugation Service Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Antibody Conjugation Service Market Size by Country (2026-2031) & (US$ Million)
 Table 48. ProSci, Inc Company Details
 Table 49. ProSci, Inc Business Overview
 Table 50. ProSci, Inc Antibody Conjugation Service Product
 Table 51. ProSci, Inc Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 52. ProSci, Inc Recent Development
 Table 53. Thermo Fisher Scientific Company Details
 Table 54. Thermo Fisher Scientific Business Overview
 Table 55. Thermo Fisher Scientific Antibody Conjugation Service Product
 Table 56. Thermo Fisher Scientific Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 57. Thermo Fisher Scientific Recent Development
 Table 58. Abcam Company Details
 Table 59. Abcam Business Overview
 Table 60. Abcam Antibody Conjugation Service Product
 Table 61. Abcam Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 62. Abcam Recent Development
 Table 63. Cell Signaling Technology Company Details
 Table 64. Cell Signaling Technology Business Overview
 Table 65. Cell Signaling Technology Antibody Conjugation Service Product
 Table 66. Cell Signaling Technology Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 67. Cell Signaling Technology Recent Development
 Table 68. Bio X Cell Company Details
 Table 69. Bio X Cell Business Overview
 Table 70. Bio X Cell Antibody Conjugation Service Product
 Table 71. Bio X Cell Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 72. Bio X Cell Recent Development
 Table 73. SouthernBiotech Company Details
 Table 74. SouthernBiotech Business Overview
 Table 75. SouthernBiotech Antibody Conjugation Service Product
 Table 76. SouthernBiotech Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 77. SouthernBiotech Recent Development
 Table 78. Novus Biologicals Company Details
 Table 79. Novus Biologicals Business Overview
 Table 80. Novus Biologicals Antibody Conjugation Service Product
 Table 81. Novus Biologicals Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 82. Novus Biologicals Recent Development
 Table 83. GenScript Company Details
 Table 84. GenScript Business Overview
 Table 85. GenScript Antibody Conjugation Service Product
 Table 86. GenScript Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 87. GenScript Recent Development
 Table 88. Leinco Technologies Company Details
 Table 89. Leinco Technologies Business Overview
 Table 90. Leinco Technologies Antibody Conjugation Service Product
 Table 91. Leinco Technologies Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 92. Leinco Technologies Recent Development
 Table 93. Standard BioTools Company Details
 Table 94. Standard BioTools Business Overview
 Table 95. Standard BioTools Antibody Conjugation Service Product
 Table 96. Standard BioTools Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 97. Standard BioTools Recent Development
 Table 98. AlphaThera Company Details
 Table 99. AlphaThera Business Overview
 Table 100. AlphaThera Antibody Conjugation Service Product
 Table 101. AlphaThera Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 102. AlphaThera Recent Development
 Table 103. Creative Biolabs Company Details
 Table 104. Creative Biolabs Business Overview
 Table 105. Creative Biolabs Antibody Conjugation Service Product
 Table 106. Creative Biolabs Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 107. Creative Biolabs Recent Development
 Table 108. Antibodies Company Details
 Table 109. Antibodies Business Overview
 Table 110. Antibodies Antibody Conjugation Service Product
 Table 111. Antibodies Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 112. Antibodies Recent Development
 Table 113. Boster Biological Technology Company Details
 Table 114. Boster Biological Technology Business Overview
 Table 115. Boster Biological Technology Antibody Conjugation Service Product
 Table 116. Boster Biological Technology Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 117. Boster Biological Technology Recent Development
 Table 118. Cygnus Technologies Company Details
 Table 119. Cygnus Technologies Business Overview
 Table 120. Cygnus Technologies Antibody Conjugation Service Product
 Table 121. Cygnus Technologies Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 122. Cygnus Technologies Recent Development
 Table 123. Cayman Chemical Company Details
 Table 124. Cayman Chemical Business Overview
 Table 125. Cayman Chemical Antibody Conjugation Service Product
 Table 126. Cayman Chemical Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 127. Cayman Chemical Recent Development
 Table 128. GeneTex Company Details
 Table 129. GeneTex Business Overview
 Table 130. GeneTex Antibody Conjugation Service Product
 Table 131. GeneTex Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 132. GeneTex Recent Development
 Table 133. ProteoGenix Company Details
 Table 134. ProteoGenix Business Overview
 Table 135. ProteoGenix Antibody Conjugation Service Product
 Table 136. ProteoGenix Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 137. ProteoGenix Recent Development
 Table 138. Levena Biopharma Company Details
 Table 139. Levena Biopharma Business Overview
 Table 140. Levena Biopharma Antibody Conjugation Service Product
 Table 141. Levena Biopharma Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 142. Levena Biopharma Recent Development
 Table 143. Merck Company Details
 Table 144. Merck Business Overview
 Table 145. Merck Antibody Conjugation Service Product
 Table 146. Merck Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 147. Merck Recent Development
 Table 148. Lonza Company Details
 Table 149. Lonza Business Overview
 Table 150. Lonza Antibody Conjugation Service Product
 Table 151. Lonza Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 152. Lonza Recent Development
 Table 153. Charles River Company Details
 Table 154. Charles River Business Overview
 Table 155. Charles River Antibody Conjugation Service Product
 Table 156. Charles River Revenue in Antibody Conjugation Service Business (2020-2025) & (US$ Million)
 Table 157. Charles River Recent Development
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Antibody Conjugation Service Picture
 Figure 2. Global Antibody Conjugation Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antibody Conjugation Service Market Share by Type: 2024 VS 2031
 Figure 4. Chemical Compound Features
 Figure 5. Fluorescent Group Features
 Figure 6. Isotope Features
 Figure 7. Protein Features
 Figure 8. Global Antibody Conjugation Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Antibody Conjugation Service Market Share by Application: 2024 VS 2031
 Figure 10. Biotechnology Case Studies
 Figure 11. Medical Case Studies
 Figure 12. University Case Studies
 Figure 13. Others Case Studies
 Figure 14. Antibody Conjugation Service Report Years Considered
 Figure 15. Global Antibody Conjugation Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Antibody Conjugation Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Antibody Conjugation Service Market Share by Region: 2024 VS 2031
 Figure 18. Global Antibody Conjugation Service Market Share by Players in 2024
 Figure 19. Global Top Antibody Conjugation Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Conjugation Service as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Antibody Conjugation Service Revenue in 2024
 Figure 21. North America Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Antibody Conjugation Service Market Share by Country (2020-2031)
 Figure 23. United States Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Antibody Conjugation Service Market Share by Country (2020-2031)
 Figure 27. Germany Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Antibody Conjugation Service Market Share by Region (2020-2031)
 Figure 35. China Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Antibody Conjugation Service Market Share by Country (2020-2031)
 Figure 43. Mexico Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Antibody Conjugation Service Market Share by Country (2020-2031)
 Figure 47. Turkey Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Antibody Conjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. ProSci, Inc Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 52. Abcam Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 53. Cell Signaling Technology Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 54. Bio X Cell Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 55. SouthernBiotech Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 56. Novus Biologicals Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 57. GenScript Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 58. Leinco Technologies Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 59. Standard BioTools Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 60. AlphaThera Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 61. Creative Biolabs Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 62. Antibodies Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 63. Boster Biological Technology Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 64. Cygnus Technologies Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 65. Cayman Chemical Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 66. GeneTex Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 67. ProteoGenix Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 68. Levena Biopharma Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 69. Merck Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 70. Lonza Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 71. Charles River Revenue Growth Rate in Antibody Conjugation Service Business (2020-2025)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Metaproteomics Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-5M19888
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-33S19787
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Grade Pregelatinized Starch Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-6P20101
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Bupivacaine Extended-Release Liposome Injection Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-10L20096
Thu Oct 02 00:00:00 UTC 2025

Add to Cart